Moors, Tim E.
Morella, Martino L.
Bertran-Cobo, Cesc
Geut, Hanneke
Udayar, Vinod
Timmermans-Huisman, Evelien
Ingrassia, Angela M. T.
Brevé, John J. P.
Bol, John G. J. M.
Bonifati, Vincenzo
Jagasia, Ravi
van de Berg, Wilma D. J. http://orcid.org/0000-0002-6175-5357
Article History
Received: 3 August 2023
Revised: 14 February 2024
Accepted: 14 February 2024
First Online: 6 April 2024
Declarations
:
: The authors declare no competing interests. M.L.M, T.E.M., V.U. and R.J. are or were full-time employees of Roche/F. Hoffmann-La Roche Ltd, and may additionally hold Roche stock/stock options.
: <i>Post-mortem</i> human brain tissue from clinically diagnosed and neuropathologically verified donors with PD, DLB, iLBD as well as non-demented controls was collected by the Netherlands Brain Bank (NBB, ExternalRef removed). In compliance with all local ethical and legal guidelines, informed consent for brain autopsy and the use of brain tissue and clinical information for scientific research was given by either the donor or the next of kin. The Code of Conduct and Ethical Declaration of the NBB are publicly accessible [CitationRef removed, CitationRef removed, CitationRef removed]. The procedures of the Netherlands Brain Bank (Amsterdam, The Netherlands) were approved by the Institutional Review Board and Medical Ethical Board (METC) from the VU University Medical Center (VUmc), Amsterdam.